Emflaza

Deflazacort

Emflazaは、満5歳以上の患者のデュシェンヌ型筋ジストロフィー(DMD)の治療のために指示されたコルチコステロイドである。
more
パッケージ あたり 錠剤 価格 節約 ご注文
180 tablet
¥ 105.23
¥ 18941.02¥ 105.23
¥ 33487.49
120 tablet
¥ 121.40
¥ 14568.33¥ 121.40
¥ 20384.00
90 tablet
¥ 145.68
¥ 13110.77¥ 145.68
¥ 13103.48
60 tablet
¥ 182.07
¥ 10924.43¥ 182.07
¥ 6551.74
30 tablet
¥ 291.27
¥ 8738.08¥ 291.27
パッケージ あたり 錠剤 価格 節約 ご注文
120 tablet
無料航空便配送 Hot
¥ 667.99
¥ 80158.62¥ 667.99
¥ 14546.47
90 tablet
無料航空便配送 Hot
¥ 704.41
¥ 63396.66¥ 704.41
¥ 7632.16
60 tablet
無料航空便配送 Hot
¥ 728.66
¥ 43719.57¥ 728.66
¥ 3632.97
36 tablet
無料航空便配送 Hot
¥ 769.07
¥ 27686.39¥ 769.07
¥ 725.14
24 tablet
¥ 789.21
¥ 18941.02¥ 789.21
パッケージ あたり 錠剤 価格 節約 ご注文
90 tablet
無料航空便配送 Hot
¥ 809.68
¥ 72870.81¥ 809.68
¥ 14555.58
60 tablet
無料航空便配送 Hot
¥ 874.42
¥ 52464.94¥ 874.42
¥ 5819.32
36 tablet
無料航空便配送 Hot
¥ 931.02
¥ 33516.64¥ 931.02
¥ 1453.92
24 tablet
無料航空便配送 Hot
¥ 971.40
¥ 23313.70¥ 971.40
Emflaza

ブランド

製造元

  • Lupin

病衣

  • Duchenne Muscular Dystrophy / DMD

Deflazacort tablets

What is this medicine?

Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

What should I tell my health care providers before I take this medicine?

They need to know if you have any of these conditions:

  • Hypersensitivity to deflazacort;
  • Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
  • Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
  • Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
  • Gastrointestinal Perforation: GI disorders;
  • Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
  • Effects on Bones: decreases in bone mineral density;
  • Serious Skin Rashes;
  • Ophthalmic Effects: May include cataracts, infections, and glaucoma;
  • Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.

How should I use this medicine?

The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..

What may interact with this medicine?

  • Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
  • Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.

What side effects may I notice from this medicine?

The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.